Wistar Fights COVID-19

Wistar Science. Wistar Legacy.

Ways to Support

Recent Press Releases

View all ›

Wistar Scientists Discover New Mechanism Through Which Senescent Cells Turn On Genes That Encode for Secreted Tumor-regulating Factors 

Richard M. Horowitz Appointed Chair of The Wistar Institute’s Board of Trustees

RNA Editing Protein ADAR1 Protects Telomeres and Supports Proliferation in Cancer Cells
 

Our Centers

Maureen and lab

Cancer Center

Wistar is a National Cancer Institute Cancer Center in basic research and has held this designation since 1972.
David and Ami_In the Lab1

Vaccine & Immunotherapy Center

Improving health around the globe by creating and advancing vaccines and immunotherapies.

Upcoming events

View all events ›

Scientific Seminar

Virtual Distinguished Lectures in Cancer Research Series: Mechanisms of Chromosome Folding

Scientific Seminar

Virtual Distinguished Lectures in Cancer Research Series: Altered Protein Glycosylation in Cancer and Roles in Oncogenesis

Scientific Seminar

Virtual Distinguished Lectures in Cancer Research Series: Metabolism, Cellular Decisions and the Language that Unites Them

125 Years of Discovery and Counting

View full timeline ›
Dmitry Gabrilovich, M.D., Ph.D.

Tumor Immunology Discoveries

In 2016, Dmitry I. Gabrilovich, M.D., Ph.D., and his research team identified a marker for myeloid-derived suppressor cells (MDSCs), a population of immune cells implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy. The new marker has a potential clinical impact as it could be used to help direct treatment decisions and to target MDSCs for therapeutic benefit.

View Full Timeline

Accelerating the future

Right now, Wistar Science is making discoveries that will advance human health.

Support Today